Expertise in
2
conditions

Dr. Mark S. Silverberg

Emergency Medicine
Nyc Health Hospitals / Kings County
451 Clarkson Ave, 
Brooklyn, NY 
Accepting New Patients
Referral may be required
Before you request
Expertise in
2
conditions
Nyc Health Hospitals / Kings County
451 Clarkson Ave, 
Brooklyn, NY 

Overview

Mark Silverberg is an Emergency Medicine provider practicing medicine in Brooklyn, New York.

Dr. Silverberg is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Colonoscopy and Endoscopy.

He is actively involved in clinical research, co-authoring 224 peer reviewed articles and participating in 5 clinical trials. Dr. Silverberg is currently accepting new patients.

Specialties

Emergency Medicine

Licenses

Emergency Medicine in NY

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health First
  • HMO
  • POS
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
MetroPlus Health
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

Nyc Health Hospitals / Kings County
451 Clarkson Ave, Brooklyn, NY 11203

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
Pharmacokinetics of Infliximab and Tumor Necrosis Factor Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
Enrollment Status: Active_not_recruiting
Publish Date: June 02, 2026
Intervention Type: Drug
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
VERDICT: In actiVE Ulcerative Colitis, a RanDomIzed Controlled Trial for Determination of the Optimal Treatment Target
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2026
Intervention Type: Biological
Study Drug: Vedolizumab
Study Phase: Phase 4
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
A Phase-III, Randomized, Double-blind, Parallel-group, Placebo-controlled, International, Multicentre Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Patients With Crohn's Disease Over a Period of 24 Weeks and a Follow-up Period up to 52 Weeks
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Drug, Other
Study Drug: Cx601
Study Phase: Phase 3
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
An Adaptive Phase 2, Randomized, Double Blind, Placebo Controlled Study of LY3471851 (NKTR 358) in Patients With Moderately to Severely Active Ulcerative Colitis
Enrollment Status: Terminated
Publish Date: September 05, 2023
Intervention Type: Drug
Study Drug: LY3471851
Study Phase: Phase 2
PhaRmacOkinetics and PHarmacodynamic BiomarkErs of Janus Kinase Inhibitor Therapy in PatIents With Ulcerative Colitis (PROPHETIC)
PhaRmacOkinetics and PHarmacodynamic BiomarkErs of Janus Kinase Inhibitor Therapy in PatIents With Ulcerative Colitis (PROPHETIC)
Enrollment Status: Terminated
Publish Date: January 04, 2022
Intervention Type: Drug
View 4 Less Clinical Trials

223 Total Publications

Exome sequencing directly implicates 68 genes in inflammatory bowel disease.
Exome sequencing directly implicates 68 genes in inflammatory bowel disease.
Journal: medRxiv : the preprint server for health sciences
Published: May 25, 2026
Similar Doctors
Expertise in
1
conditions
Dr. Theresa Patel
Emergency Medicine
Expertise in
1
conditions
Dr. Theresa Patel
Emergency Medicine
Referral may be required
Before you request

South Nassau Communities Hospital

1 Healthy Way, 
Oceanside, NY 
 (16.4 miles away)
516-632-3000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Theresa Patel is an Emergency Medicine provider practicing medicine in Oceanside, New York. Dr. Patel is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Schizoaffective Disorder. Dr. Patel is currently accepting new patients.

Expertise in
1
conditions
Dr. Kurt R. Dischner
Emergency Medicine
Expertise in
1
conditions
Dr. Kurt R. Dischner
Emergency Medicine
Referral may be required
Before you request

Mercy Medical Center

1000 N Village Ave, 
Rockville Centre, NY 
 (16.4 miles away)
516-705-2525
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kurt Dischner is an Emergency Medicine provider practicing medicine in Rockville Centre, New York. Dr. Dischner is highly rated in 1 condition, according to our data. His clinical expertise encompasses Schizoaffective Disorder. Dr. Dischner is currently accepting new patients.

Expertise in
1
conditions
Dr. Chantel Oshea
Emergency Medicine
Expertise in
1
conditions
Dr. Chantel Oshea
Emergency Medicine
Referral may be required
Before you request

Glen Cove Hospital

101 Saint Andrews Ln, 
Glen Cove, NY 
 (22.4 miles away)
516-674-7300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Chantel Oshea is an Emergency Medicine provider practicing medicine in Glen Cove, New York. Dr. Oshea is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Schizoaffective Disorder. Dr. Oshea is currently accepting new patients.

Frequently Asked Questions about Dr. Mark S. Silverberg

How do I make an appointment with Dr. Mark S. Silverberg?

You can book an appointment with Dr. Mark S. Silverberg by calling their office at 718-245-3131. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Mark S. Silverberg a top-rated expert for Colonoscopy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mark S. Silverberg is classified as an Advanced expert for Colonoscopy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Mark S. Silverberg specialize in?

While Dr. Mark S. Silverberg is a Emergency Medicine, they have specific expertise in Colonoscopy, Endoscopy, and Tissue Biopsy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Emergency Medicine.

Does Dr. Mark S. Silverberg participate in research or clinical trials?

Yes. Dr. Mark S. Silverberg has published 223 articles and abstracts on conditions like Colonoscopy. You can view a list of Dr. Mark S. Silverberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Mark S. Silverberg accept my insurance?

Dr. Mark S. Silverberg accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 718-245-3131 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Silverberg's expertise for a condition
ConditionClose
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile